Phacilitate: Advanced Therapies Week 2024

Phacilitate’s Advanced Therapies Week 2024 brings together developers, investors, and solution providers across the biotech industry whose goal is to bring cell and gene therapies to patients.

BGL Managing Director Christoph Brandenberger will be attending this year’s conference and available to discuss the life sciences market, including upcoming opportunities in medical device M&A and biotech.

BGL’s Diagnostics, Research Tools & Medical Devices investment banking team has decades of experience advising companies across the diagnostics and device landscape. With this in-depth knowledge and background, we have provided M&A and capital markets strategies for a wide range of companies in this sector.